Fachrepositorium Lebenswissenschaften

12 Treffer

Seiten

Suche

Publisso-Menue

Seiten

Diagnostic and therapeutic delays in lung cancer during the COVID-19 pandemic: a single center experience at a German Cancer center

2024 . Tarawneh, Thomas S. | Mack, Elisabeth K. M. | Faoro, Charis | Neubauer, Andreas | Middeke, Martin | Kirschbaum, Andreas | Holland, Angélique

Effect of TTF-1 expression on progression free survival of immunotherapy and chemo-/immunotherapy in patients with non-small cell lung cancer

2024 . Uhlenbruch, Mark | Krüger, Stefan

Prognostic value of metabolic tumor volume on [18F]FDG PET/CT in addition to the TNM classification system of locally advanced non-small cell lung cancer

2024 . Brose, Alexander | Miederer, Isabelle | König, Jochem | Gkika, Eleni | Sahlmann, Jörg | Schimek-Jasch, Tanja | Schreckenberger, Mathias | Nestle, Ursula | Kappes, Jutta | Miederer, Matthias

Molecular classification and biomarkers of outcome with immunotherapy in extensive-stage small-cell lung cancer: analyses of the CASPIAN phase 3 study

Assessment of the physiological effects and safety of transpulmonary chemoembolization with doxorubicin on pulmonary tissue using a human-isolated lung perfusion model

2024 . Slama, Alexis | Steinberg, Hannah | Collaud, Stéphane | Okumus, Özlem | Hilger, Ralph-Axel | Bauer, Sebastian | Schildhaus, Hans-Ulrich | Aigner, Clemens | Schaarschmidt, Benedikt Michael

Age differences in the treatment of lung cancer–a cohort study among 42,000 patients from Germany

2024 . Rischke, Nikolaj | Kanbach, Josephine | Haug, Ulrike

First-site-metastasis pattern in patients with inoperable stage III NSCLC treated with concurrent chemoradiotherapy with or without immune check-point inhibition: a retrospective analysis

2023 . Hofstetter, Kerstin | Taugner, Julian | Käsmann, Lukas | Mansoorian, Sina | Flörsch, Benedikt | Eze, Chukwuka | Tufman, Amanda | Reinmuth, Niels | Duell, Thomas | Belka, Claus | Manapov, Farkhad

Differential role of residual metabolic tumor volume in inoperable stage III NSCLC after chemoradiotherapy ± immune checkpoint inhibition

2021 . Unterrainer, Marcus | Taugner, Julian | Käsmann, Lukas | Tufman, Amanda | Reinmuth, Niels | Li, Minglun | Mittlmeier, Lena M. | Bartenstein, Peter | Kunz, Wolfgang G. | Ricke, Jens | Belka, Claus | Eze, Chukwuka | Manapov, Farkhad

Planning target volume as a predictor of disease progression in inoperable stage III non-small cell lung cancer patients treated with chemoradiotherapy and concurrent and/or sequential immune checkpoint inhibition

2021 . Taugner, Julian | Käsmann, Lukas | Karin, Monika | Eze, Chukwuka | Flörsch, Benedikt | Guggenberger, Julian | Li, Minglun | Tufman, Amanda | Reinmuth, Niels | Duell, Thomas | Belka, Claus | Manapov, Farkhad

Real-world prospective analysis of treatment patterns in durvalumab maintenance after chemoradiotherapy in unresectable, locally advanced NSCLC patients

2021 . Taugner, Julian | Käsmann, Lukas | Eze, Chukwuka | Rühle, Alexander | Tufman, Amanda | Reinmuth, Niels | Duell, Thomas | Belka, Claus | Manapov, Farkhad

Seiten